221 related articles for article (PubMed ID: 29408278)
1. New developments on skin fibrosis - Essential signals emanating from the extracellular matrix for the control of myofibroblasts.
Schulz JN; Plomann M; Sengle G; Gullberg D; Krieg T; Eckes B
Matrix Biol; 2018 Aug; 68-69():522-532. PubMed ID: 29408278
[TBL] [Abstract][Full Text] [Related]
2. Matrix Stiffness: the Conductor of Organ Fibrosis.
Santos A; Lagares D
Curr Rheumatol Rep; 2018 Jan; 20(1):2. PubMed ID: 29349703
[TBL] [Abstract][Full Text] [Related]
3. Enhanced deposition of cartilage oligomeric matrix protein is a common feature in fibrotic skin pathologies.
Agarwal P; Schulz JN; Blumbach K; Andreasson K; Heinegård D; Paulsson M; Mauch C; Eming SA; Eckes B; Krieg T
Matrix Biol; 2013 Aug; 32(6):325-31. PubMed ID: 23507196
[TBL] [Abstract][Full Text] [Related]
4. Fibroblast growth factor-2 regulates human cardiac myofibroblast-mediated extracellular matrix remodeling.
Svystonyuk DA; Ngu JM; Mewhort HE; Lipon BD; Teng G; Guzzardi DG; Malik G; Belke DD; Fedak PW
J Transl Med; 2015 May; 13():147. PubMed ID: 25948488
[TBL] [Abstract][Full Text] [Related]
5. Myocardial fibroblast-matrix interactions and potential therapeutic targets.
Goldsmith EC; Bradshaw AD; Zile MR; Spinale FG
J Mol Cell Cardiol; 2014 May; 70():92-9. PubMed ID: 24472826
[TBL] [Abstract][Full Text] [Related]
6. Relaxin and extracellular matrix remodeling: Mechanisms and signaling pathways.
Ng HH; Shen M; Samuel CS; Schlossmann J; Bennett RG
Mol Cell Endocrinol; 2019 May; 487():59-65. PubMed ID: 30660699
[TBL] [Abstract][Full Text] [Related]
7. Understanding the origin, activation and regulation of matrix-producing myofibroblasts for treatment of fibrotic disease.
Kramann R; DiRocco DP; Humphreys BD
J Pathol; 2013 Nov; 231(3):273-89. PubMed ID: 24006178
[TBL] [Abstract][Full Text] [Related]
8. Evasion of apoptosis by myofibroblasts: a hallmark of fibrotic diseases.
Hinz B; Lagares D
Nat Rev Rheumatol; 2020 Jan; 16(1):11-31. PubMed ID: 31792399
[TBL] [Abstract][Full Text] [Related]
9. Tensin 1 Is Essential for Myofibroblast Differentiation and Extracellular Matrix Formation.
Bernau K; Torr EE; Evans MD; Aoki JK; Ngam CR; Sandbo N
Am J Respir Cell Mol Biol; 2017 Apr; 56(4):465-476. PubMed ID: 28005397
[TBL] [Abstract][Full Text] [Related]
10. Human Fibrotic Diseases: Current Challenges in Fibrosis Research.
Rosenbloom J; Macarak E; Piera-Velazquez S; Jimenez SA
Methods Mol Biol; 2017; 1627():1-23. PubMed ID: 28836191
[TBL] [Abstract][Full Text] [Related]
11. GPRC5B promotes collagen production in myofibroblasts.
Takizawa N; Hironaka T; Mae K; Ueno T; Horii Y; Nagasaka A; Nakaya M
Biochem Biophys Res Commun; 2021 Jul; 561():180-186. PubMed ID: 34023784
[TBL] [Abstract][Full Text] [Related]
12. FGF2-mediated attenuation of myofibroblast activation is modulated by distinct MAPK signaling pathways in human dermal fibroblasts.
Dolivo DM; Larson SA; Dominko T
J Dermatol Sci; 2017 Dec; 88(3):339-348. PubMed ID: 28899582
[TBL] [Abstract][Full Text] [Related]
13. Mechano-therapeutics: Targeting Mechanical Signaling in Fibrosis and Tumor Stroma.
Tschumperlin DJ; Lagares D
Pharmacol Ther; 2020 Aug; 212():107575. PubMed ID: 32437826
[TBL] [Abstract][Full Text] [Related]
14. Molecular imaging of the cardiac extracellular matrix.
de Haas HJ; Arbustini E; Fuster V; Kramer CM; Narula J
Circ Res; 2014 Feb; 114(5):903-15. PubMed ID: 24577969
[TBL] [Abstract][Full Text] [Related]
15. Systemic sclerosis with multiple nodules: characterization of the extracellular matrix.
Moinzadeh P; Agarwal P; Bloch W; Orteu C; Hunzelmann N; Eckes B; Krieg T
Arch Dermatol Res; 2013 Sep; 305(7):645-52. PubMed ID: 23836353
[TBL] [Abstract][Full Text] [Related]
16. Notch signalling regulates fibroblast activation and collagen release in systemic sclerosis.
Dees C; Tomcik M; Zerr P; Akhmetshina A; Horn A; Palumbo K; Beyer C; Zwerina J; Distler O; Schett G; Distler JH
Ann Rheum Dis; 2011 Jul; 70(7):1304-10. PubMed ID: 21450749
[TBL] [Abstract][Full Text] [Related]
17. Myofibroblasts in murine cutaneous fibrosis originate from adiponectin-positive intradermal progenitors.
Marangoni RG; Korman BD; Wei J; Wood TA; Graham LV; Whitfield ML; Scherer PE; Tourtellotte WG; Varga J
Arthritis Rheumatol; 2015 Apr; 67(4):1062-73. PubMed ID: 25504959
[TBL] [Abstract][Full Text] [Related]
18. ADAM10-mediated ephrin-B2 shedding promotes myofibroblast activation and organ fibrosis.
Lagares D; Ghassemi-Kakroodi P; Tremblay C; Santos A; Probst CK; Franklin A; Santos DM; Grasberger P; Ahluwalia N; Montesi SB; Shea BS; Black KE; Knipe R; Blati M; Baron M; Wu B; Fahmi H; Gandhi R; Pardo A; Selman M; Wu J; Pelletier JP; Martel-Pelletier J; Tager AM; Kapoor M
Nat Med; 2017 Dec; 23(12):1405-1415. PubMed ID: 29058717
[TBL] [Abstract][Full Text] [Related]
19. Myofibroblast-mediated mechanisms of pathological remodelling of the heart.
Weber KT; Sun Y; Bhattacharya SK; Ahokas RA; Gerling IC
Nat Rev Cardiol; 2013 Jan; 10(1):15-26. PubMed ID: 23207731
[TBL] [Abstract][Full Text] [Related]
20. Linking myofibroblast generation and microvascular alteration: The role of CD248 from pathogenesis to therapeutic target (Review).
Di Benedetto P; Ruscitti P; Liakouli V; Del Galdo F; Giacomelli R; Cipriani P
Mol Med Rep; 2019 Aug; 20(2):1488-1498. PubMed ID: 31257535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
